Psyence Biomedical names Jody Aufrichtig as CEO as Neil Maresky transitions to lead clinical development
Reuters
Oct 10
Psyence Biomedical names Jody Aufrichtig as CEO as Neil Maresky transitions to lead clinical development
Psyence Biomedical Ltd. has announced that Dr. Neil Maresky has stepped down as Chief Executive Officer and Director to become the company's Global Head of Clinical Development. Jody Aufrichtig, the company's Chairman, has taken on the role of Chief Executive Officer and will oversee corporate operations. The company will fill the resulting Board vacancy at a later date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Psyence Biomedical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-097819), on October 09, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.